vimarsana.com

Latest Breaking News On - Analyst recommendations for amylyx pharmaceuticals - Page 2 : vimarsana.com

SVB Leerink Lowers Amylyx Pharmaceuticals (NASDAQ:AMLX) to Market Perform

SVB Leerink downgraded shares of Amylyx Pharmaceuticals (NASDAQ:AMLX – Free Report) from an outperform rating to a market perform rating in a research report released on Monday morning, Marketbeat reports. Several other equities research analysts have also recently commented on the company. Robert W. Baird cut Amylyx Pharmaceuticals from an outperform rating to a neutral […]

Amylyx Pharmaceuticals (NASDAQ:AMLX) Stock Rating Lowered by SVB Leerink

Amylyx Pharmaceuticals (NASDAQ:AMLX – Get Free Report) was downgraded by investment analysts at SVB Leerink from an “outperform” rating to a “market perform” rating in a research note issued to investors on Monday, Marketbeat Ratings reports. AMLX has been the topic of a number of other reports. The Goldman Sachs Group reissued a “neutral” rating […]

Amylyx Pharmaceuticals (NASDAQ:AMLX) Earns Neutral Rating from The Goldman Sachs Group

The Goldman Sachs Group restated their neutral rating on shares of Amylyx Pharmaceuticals (NASDAQ:AMLX – Free Report) in a report released on Friday morning, Marketbeat Ratings reports. Several other brokerages have also recently issued reports on AMLX. Robert W. Baird assumed coverage on shares of Amylyx Pharmaceuticals in a report on Wednesday, January 3rd. They […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.